Finanzwire Finanzwire
Basculer en Français
10688 Companies
228289 Keywords
156808 Articles
121064 Press releases
Headlines Articles Press releases PepperLime Health Remove
  1. Home
  2. Companies
  3. PepperLime Health
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/02/2024 at 00:16, 2 years 5 months ago

    PepperLime Health Acquisition Corporation Contemplates Potential Alternatives to Liquidation, Awaits Further Developments

    PepperLime Health Acquisition Corporation explores options following announcement of liquidation intention. Update expected soon
    PepperLime Health Acquisition Corporation Liquidation Blank-check Company Business Combinations SEC
    Logo of PepperLime Health
  • PRESS RELEASE

    published on 01/25/2024 at 22:00, 2 years 5 months ago

    PepperLime Health Acquisition Corporation Announces Plan to Liquidate

    PepperLime Health Acquisition Corporation (NASDAQ:PEPL) has announced its intention to liquidate and distribute funds to record holders by February 8, 2024. The last day of trading on Nasdaq will be February 7, 2024. The company was unable to consummate an initial business combination. For more information, please refer to the original press release.
    Nasdaq PepperLime Health Acquisition Corporation NASDAQ:PEPL Liquidation Business Combination
    Logo of PepperLime Health
Accesswire
  • Published on 07/06/2026 at 23:32, 7 hours 34 minutes ago

    Marrelli Capital Limited - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.

  • Published on 07/06/2026 at 23:30, 7 hours 36 minutes ago

    1742096 Ontario Ltd. - Early Warning Regarding Acquisition of Common Shares of BE Resources Inc.

  • Published on 07/06/2026 at 19:25, 11 hours 41 minutes ago

    Critical Elements Provides an Update on Its 10,000-Meter Summer Drill Program at Rose West

  • Published on 07/06/2026 at 17:00, 14 hours 6 minutes ago

    PPX Mining Reports Second Consecutive Monthly Historical Record of Net Profit Interest Earned at Callanquitas Mine

  • Published on 07/06/2026 at 14:30, 16 hours 36 minutes ago

    As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

View all ACCESSWIRE
EQS Group
  • Published on 07/07/2026 at 06:45, 21 minutes ago

    Shanghai - New York: to Become a Benchmark for China-U.S. Subnational Cooperation

  • Published on 07/07/2026 at 06:43, 23 minutes ago

    Heading

  • Published on 07/07/2026 at 02:05, 5 hours 1 minute ago

    Gravity Game Unite Launches 2nd Open Beta Test for PC MMORPG Ragnarok Zero: Global

  • Published on 07/07/2026 at 01:05, 6 hours 1 minute ago

    ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows

  • Published on 07/06/2026 at 22:05, 9 hours 1 minute ago

    Abivax Announces Closing of $920 Million Public Offering

View all EQS
Les Echos
  • Published on 07/06/2026 at 18:00, 13 hours 6 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of June 26, 2026

  • Published on 07/06/2026 at 17:59, 13 hours 6 minutes ago

    Acquisition of Xypex in construction chemicals, a leader in high value-added waterproofing solutions

  • Published on 07/06/2026 at 17:45, 13 hours 21 minutes ago

    Update on liquidity contract as of 30 06 26

  • Published on 07/06/2026 at 17:45, 13 hours 21 minutes ago

    Half-year report on the liquidity contract as of June 30, 2026

  • Published on 07/06/2026 at 17:45, 13 hours 21 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy